Thermo Fisher said on Wednesday it will buy Sanofi's manufacturing site in Ridgefield, New Jersey, to produce critical ...

Emcure Pharma stock was quoting at ₹1,382.5, up 1.5 per cent from the previous day's close of ₹1,362.5 as the company ...

The partnership enhances Emcure’s existing diabetes portfolio and reinforces its efforts to expand access to affordable, high ...

Sanofi announces extension of Blueprint tender offer Paris, July 17, 2025. Sanofi today announces that Rothko Merger Sub, Inc., a wholly owned subsidiary of Sanofi, has extended the expiration date of ...

Emcure Pharmaceuticals and Sanofi India have announced a distribution agreement. Emcure will promote Sanofi India's oral anti ...

Second, we built a culture that values impact over broad activity. As AI increasingly handles routine tasks that once ...

Mumbai: Sanofi India has appointed Rachid Ayari as its Interim Managing Director, while continuing in his current role as Chief Financial Officer (CFO). Ayari will hold the dual role for ...

Sanofi SNY has announced that the FDA has granted a fast-track designation to its one-time intravitreal gene therapy, ...

Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced an expansion of their strategic partnership with Sanofi to enable additional U.S. drug product ...

Emcure Pharmaceuticals and Sanofi India have partnered in an exclusive distribution and promotion agreement for Sanofi's oral ...

Emcure Pharmaceuticals Ltd. and Sanofi India Limited today entered into an exclusive distribution and promotion agreement for ...

Sanofi is a high-quality, undervalued pharma giant trading near 10x P/E. Click here to read more about SNY stock and why it ...